BIONUMERIK
DEAD

Serial Number

78593946

Owner

BioNumerik Pharmaceuticals, Inc.

Attorney

Laura A. Genovese

First Use Date

May 31, 1996

Filing Date

Mar 24, 2005

Add to watchlist:

No watchlists yet
View on USPTO

BIONUMERIK Trademark

Serial Number: 78593946 • Registration: 3703574

BIONUMERIK is a trademark filed by BioNumerik Pharmaceuticals, Inc. on March 24, 2005. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

BioNumerik Pharmaceuticals, Inc. (13 trademarks)

San Antonio, TX 78229

Entity Type: 03

Trademark Details

Filing Date

March 24, 2005

Registration Date

October 27, 2009

First Use Anywhere

May 31, 1996

First Use in Commerce

September 30, 1997

Published for Opposition

July 25, 2006

Cancellation Date

June 3, 2016

Goods & Services

Pharmaceutical products for the following diseases and medical conditions; cancer; sickle cell anemia; the toxicity of side-effects of chemotherapeutic treatment; neurotoxicity; adult respiratory distress syndrome; acute renal failure treatment; septic shock or shock/ischemia; ethanol-induced physiological symptoms ("Hang-over"); ethylene glycol poisoning; radiation exposure; osteoporosis; cardiomyopathy; diabetic neuropathy; diabetic opthalmopathy; diabetic angiopathy; diabetic nephropathy; hypertension; atherosclerosis and peripheral vascular disease; ischemia; gastrointestinal distress; patients exposed to toxic chemicals; heavy metal poisoning or exposure; complications arising from AIDS; alcoholism and complications arising therefrom; acetaminophen overdosage; the renal calculi (kidney stones); inhibiting angiogenesis; Wilson's disease; Treatment for reducing toxicity associated with diabetes treatments; inflammatory bowel disorder; complication arising from tobacco smoke exposure; venomous snakebite; patients undergoing kidney dialysis or peritoneal dialysis; chemotherapy/drug extravasation injury; lymphedema; chemotherapy- or drug-induced toxicity; platinum or alkylating agent overdose; hyperbaric toxicity; chemotherapy- or radiation-induced mucositis

Filing History

CANCELLED SEC. 8 (6-YR)
Jun 3, 2016 C8..
REGISTERED-PRINCIPAL REGISTER
Oct 27, 2009 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Sep 21, 2009 REGV
ASSIGNED TO LIE
Sep 21, 2009 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 11, 2009 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 24, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 24, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 6, 2009 GNRN
NON-FINAL ACTION E-MAILED
Aug 6, 2009 GNRT
SU - NON-FINAL ACTION - WRITTEN
Aug 6, 2009 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jul 10, 2009 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 10, 2009 AITU
USE AMENDMENT FILED
Jun 16, 2009 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 16, 2009 EISU
SOU EXTENSION 5 GRANTED
Jan 9, 2009 EX5G
SOU EXTENSION 5 FILED
Jan 9, 2009 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 9, 2009 EEXT
SOU EXTENSION 4 GRANTED
Sep 23, 2008 EX4G
SOU EXTENSION 4 FILED
Sep 23, 2008 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 23, 2008 EEXT
ASSIGNED TO EXAMINER
Feb 5, 2008 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 9, 2008 TCCA
SOU EXTENSION 3 GRANTED
Nov 8, 2007 EX3G
SOU EXTENSION 3 FILED
Nov 8, 2007 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 8, 2007 EEXT
SOU EXTENSION 2 GRANTED
Sep 14, 2007 EX2G
SOU EXTENSION 2 FILED
Sep 14, 2007 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 14, 2007 EEXT
SOU EXTENSION 1 GRANTED
Apr 10, 2007 EX1G
SOU EXTENSION 1 FILED
Apr 10, 2007 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 10, 2007 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 17, 2006 NOAM
PUBLISHED FOR OPPOSITION
Jul 25, 2006 PUBO
NOTICE OF PUBLICATION
Jul 5, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 2, 2006 PREV
ASSIGNED TO LIE
May 26, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 12, 2006 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2006 TROA
NON-FINAL ACTION MAILED
Oct 20, 2005 CNRT
NON-FINAL ACTION WRITTEN
Oct 19, 2005 CNRT
ASSIGNED TO EXAMINER
Oct 19, 2005 DOCK
NEW APPLICATION ENTERED
Mar 29, 2005 NWAP